These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26458285)

  • 41. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
    Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
    Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
    Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
    Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
    Harada K; Ferdous T; Kobayashi H; Ueyama Y
    Int J Oncol; 2014 Dec; 45(6):2439-45. PubMed ID: 25230791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
    Zhang Y; Yuan Y; Wu H; Xie Z; Wu Y; Song X; Wang J; Shu W; Xu J; Liu B; Wan L; Yan Y; Ding X; Shi X; Pan Y; Li X; Yang J; Zhao X; Wang L
    Int J Cancer; 2018 Aug; 143(4):980-991. PubMed ID: 29536537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
    Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
    Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma.
    Jia L; Wang J; Wu T; Wu J; Ling J; Cheng B
    Mol Med Rep; 2017 Nov; 16(5):5779-5786. PubMed ID: 28849182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
    Pu Y; Li Q; Wang Y; Xu L; Qiao Q; Guo Y; Guo C
    BMC Cancer; 2021 Dec; 21(1):1283. PubMed ID: 34847866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
    Li R; Liu GZ; Luo SY; Chen R; Zhang JX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The inhibitory effect of metformin on oral squamous cell carcinoma].
    Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinoma.
    Liu PY; Sheu JJ; Lin PC; Lin CT; Liu YJ; Ho LI; Chang LF; Wu WC; Chen SR; Chen J; Harn YC; Lin SZ; Tsai CH; Chiou TW; Harn HJ
    Invest New Drugs; 2012 Feb; 30(1):79-89. PubMed ID: 20809206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells.
    Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Gene Ther; 2011 Mar; 18(3):176-88. PubMed ID: 21052098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma.
    Kerr C; Adhikary G; Grun D; George N; Eckert RL
    Mol Carcinog; 2018 Jan; 57(1):3-11. PubMed ID: 28796401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells.
    Fang L; Gao L; Xie L; Xiao G
    Oncol Rep; 2018 Mar; 39(3):1283-1291. PubMed ID: 29286162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
    Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
    J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.